Evaluation of micronuclei in oral squamous cell carcinoma and potentially malignant disorders via different staining techniques
DOI:
https://doi.org/10.15584/ejcem.2024.3.15Keywords:
Feulgen stain, micronuclei, oral squamous cell carcinoma, potentially malignant disordersAbstract
Introduction and aim. Oral squamous cell carcinoma (OSCC) and premalignant disorders (PMDs) are becoming common in India as the use of tobacco in different forms is increasing from a young age, and the prevalence of this disease is becoming more common in middle age. Identifying disease at earlier stages is an important measure for limiting disease incidence and improving patient prognosis. The micronuclei count can be a valid biomarker for screening suspected patients and can be helpful in educating patients about the discontinuation of treatment, diagnosing the disease in its early stages and planning a treatment for a better prognosis. Different stains that are nuclear specific can be used to identify micronuclei. The aim was to establish diagnostic efficacy of various staining techniques in OSCC and potentially malignant disorders on oral brush cytology smears with observation of micronuclei as a valid biomarker for evaluation of the disease.
Material and methods. Exfoliative cytology was done with oral brush and smears are obtained from 25 oral squamous cell carcinoma, 25 leukoplakia, 25 lichen planus, 25 oral sub mucous fibrosis patients and 15 samples with no disease. Each smear was stained with five different stains Papanicolaou (PAP), hematoxylin and eosin (H&E), toluidine blue, Leishman and Giemsa (LG) cocktail and Feulgen and observed for staining efficacy of micronuclei and cellular structures.
Results. The best stain to observe DNA content as micronuclei is Feulgen which gives clear and crisp details of micronuclei without giving any false count as it is nuclear specific stain. PAP can be the second choice stain. Micronuclei count is definitely increased in OSCC and PMDs compared to samples without disease confirming its use as biomarker.
Conclusion. Micronuclei count in oral brush cytology smears is a valid biomarker for evaluation of premalignant disorders and OSCC and can be used for detection of disease in individuals and for screening purposes of large populations at risk. Feulgen stain is best to study DNA content as micronuclei, on the other hand PAP can be used in large sampling investigations where there is lack of armamentarium.
Downloads
References
Rivera C. Essentials of oral cancer. Int J Clin Exp Pathol. 2015;8(9):11884-11894.
Lewandowska A, Rudzki G, Lewandowski T, et al. Quality of Life of Cancer Patients Treated with Chemotherapy. Int J Environ Res Public Health. 2020;17(19):6938. doi: 10.3390/ijerph17196938
Naderi NJ, Farhadi S, Sarshar S. Micronucleus assay of buccal mucosa cells in smokers with the history of smoking less and more than 10 years. Indian J Pathol Microbiol. 2012;55(4):433-438. doi: 10.4103/0377-4929.107774
Kumar N, Indira AP, David M, et al. Evaluation of Micronucleus Assay in Oral Exfoliated Buccal Cells in Potentially Malignant Disorders and Oral Squamous Cell Carcinoma. Int J Prev Clin Dent Res. 2016;3(3):173-177. doi: 10.5005/jp-journals-10052-0038
Messadi DV. Diagnostic aids for detection of oral precancerous conditions. Int J Oral Sci. 2013;5(2):59-65. doi: 10.1038/ijos.2013.24
Kamboj M, Mahajan S. Micronucleus- an upcoming marker of genotoxic damage. Clin Oral Investig. 2007;11(2):121-126. doi: 10.1007/s00784-006-0075-y
Grover S, Ahmed MB, Telagi N, Shivappa AB, Nithin KP. Evaluation of diagnostic reliability of micronuclei in potentially malignant disorders of oral cavity. CHRISMED Journal of Health and Research. 2014;1:15-20. doi: 10.4103/2348-3334.126776
Iocca O, Sollecito TP, Alawi F, et al. Potentially malignant disorders of the oral cavity and oral dysplasia: A systematic review and meta-analysis of malignant transformation rate by subtype. Head Neck. 2020;42(3):539-555. doi: 10.1002/hed.26006
Wang S, Yang M, Li R, et al. Current advances in noninvasive methods for the diagnosis of oral squamous cell carcinoma: a review. Eur J Med Res. 2023;28(1):53. doi: 10.1186/s40001-022-00916-4
Saraswathi K, Padma M. Evaluation of Cytogenic Damage in the Form of Micronuclei in Oral Exfoliated Buccal Cells in Tobacco Users. Ind J DenT Resear. 2018;9(6):773-780. doi: 10.4103/ijdr.IJDR_218_17
Metgud R, Surbhi, Smitha N, Patel S. Spritzer: For diagnostic cytopathology. J Canc Resear Therap. 2017;13(6):964-967. doi: 10.4103/0973-1482.174548.
Kamini K, Agarwal P, Kumar S, et al. Micronuclei as a Predictor for Oral Carcinogenesis. J Cytol. 2018;35(4):233-236. doi: 10.4103/JOC.JOC_141_17
Bansal H, Sandhu VS, Bhandari R, et al. Evaluation of micronuclei in tobacco users: A study in Punjabi population. Contemp Clin Dent. 2012;3(2):184-187. doi: 10.4103/0976-237X.96825
Grover S, Mujib ABR, Jahagirdar A, et al. A comparative study for selectivity of micronuclei in oral exfoliated epithelial cells. J Cytol. 2012;29(4):230-235. doi: 10.4103/0970-9371.103940
Biswas S, Garai B, Banerjee M. Genotoxic Effects of Tobacco on Buccal Epithelium: Cell Nuclear Anomalies as Biomarker. Asia Pac J Med Toxicol. 2014;3:157-162.
Kashyap B, Reddy S. Micronuclei assay of exfoliated oral buccal cells: Means to assess the nuclear abnormalities in different diseases. J Canc Resear Therap. 2012;8(2):184-191. doi: 10.4103/0973-1482.98968
Patil PV, Nikumbh DB. Efficacy of toluidine blue in cervicovaginal cytology over conventional papanicolaou stain. Arch cytol histopath research. 2018;3(2):47-51.
Sidhu K, Ramalingam K, Goyal S, et al. Comparing the Efficacy of Leishman–Giemsa Cocktail Stain, Giemsa Stain, and Papanicolaou Stain in Potentially Malignant Oral Lesions: A Study on 540 Cytological Samples. J Cytol. 2018;35(2):105-109. doi: 10.4103/joc.joc_249_16
Nancy A, Shaaban, Hanaa S, et al. Micronuclei as Biomarkers of Genetic Damage in Oral Squamous Cell Carcinoma. Alexandria Dental Journal. 2018;43:28-23.
Juneja S, Katyal S, Rathore AS, et al. Utility of DNA-Specific Stains in Micronuclei Assay as a Marker of Genotoxicity in Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma. J Cytol. 2019;36(2):111-115. doi: 10.4103/joc.joc_230_16
Holland N, Bolognesi C, Kirsch-Volders M, et al. The micronucleus assay in human buccal cells as a tool for biomonitoring DNA damage: The HUMN project perspective on current status and knowledge gaps. Mutat Res. 2008;659:93-108. doi: 10.1016/j.mrrev.2008.03.007
Tolbert PE, Shy CM, Allen JW. Micronuclei and other nuclear anomalies in buccal smears: A field test in snuff users. Am J Epidemiol. 1991;134:840-850. doi: 10.1016/0165-1161(92)90033-i
Buajeeb W, Kraivaphan P, Amornchat C, Triratana T. Frequency of micronucleated exfoliated cells in oral lichen planus. Mutat Res. 2007;627:191-196. doi: 10.1016/j.mrgentox.2006.10.010
Samanta S, Dey P. Micronucleus and its applications. Diagn Cytopathol. 2012;40:84-90. doi: 10.1002/dc.21592
Chieco P, Derenzini M. The Feulgen reaction 75 years on. Histochem Cell Biol. 2017;119(6):603-609. doi: 10.1016/j.acthis.2017.07.002
Kumar M, Prasad UC, Chandolia B, et al. Can Feulgen Stain be a Reliable Biomarker over PAP Stain for Estimation of Micronuclei Score? J Clin Diag Res. 2016;10(10):7-11. doi: 10.7860/JCDR/2016/18859.8630
Belgaumi UI, Shetty P. Leishman Giemsa cocktail as a new, potentially useful cytological technique comparable to Papanicolaou staining for oral cancer diagnosis. J Cytol. 2013;30:18-22. doi: 10.4103/0970-9371.107507
Agrawal A, Kumar K, Chandra SH, Agrawal KC. Comparative Analysis Study of Efficacy of Papanicolaousmear & Leishman-Giemsa Cytological Technique in the Diagnosis of Oral Neoplastic Lesions. IJSR. 2019;8:2.
Gupta N, Rakshit A, Srivastava S, et al. Comparative evaluation of micronuclei in exfoliated oral epithelial cells in potentially malignant disorders and malignant lesions using special stains. J Oral Maxillofac Pathol. 2019;23(1):157. doi: 10.4103/jomfp.jomfp_164_17
Bhatnagar A, Madhav N, Kumar S, et al. Evaluation of Micronuclei in Potentially Malignant Disorders and Oral Cancers: A Cytological Assay. J Ind Acad Ora Medic & Rad. 2023;35:3:368-372.
Shashikala R, Indira AP, Manjunath GS, et al. Role of micronucleus in oral exfoliative cytology. J Pharm Bioallied Sci. 2015;7:2:409-413. doi: 10.4103/0975-7406.163472
Autrup H, Seremet T, Arenholt D, Dragsted L, Jepsen A. Metabolism of benzopyrene by cultured rat and human buccal mucosa cells. Carcinogenesis 1985;6:1761-1765. doi: 10.1093/carcin/6.12.1761
Vondracek M, Xi Z, Larsson P, et al. Cytochrome P450 expression and related metabolism in human buccal mucosa. Carcinogenesis. 2001;22:481-488. doi: 10.1093/carcin/22.3.481
Sarto F, Finotto S, Giacomelli L, Mazzotti D, Toraanin R, Levis AG. The micronucleus assay in exfoliated cells of the human buccal mucosa. Mutagenesis. 1987;2:11-17. doi: 10.1093/mutage/2.1.11
Jadhav K, Gupta N, Ahmed M. Micronuclei: An essential biomarker in oral exfoliated cells for grading of oral squamous cell carcinoma. J Cytol. 2011;28(1):7-12. doi: 10.4103/0970-9371.76941
Sivasankari P, Kaur S, Reddy KS, Vivekanandam S, Rao RK. Micronucleus index: An early diagnosis in oral carcinoma. J Anat Soc India. 2008;57:8-13.
Dindgire SL, Gosavi S, Kumawat R, Ganvir S, Hazarey V. Comparative study of exfoliated oral mucosal cell micronucleus frequency in potentially malignant and malignant lesions. Int J Oral Maxillofac Pathol. 2012;3:15-20.
Dave GT, Parikh N, Patel N, Joshi H. Evaluation of Micronucleus Frequencies in Exfoliated Buccal Cells of Potentially Malignant Disorder Subjects Using Feulgen Stain. Indian J Dent Adv. 2019;11(3):86-92.
Sharma D, Sandhu S, Bansal H, Gupta S. Distinct perturbations of oral squamous cell carcinoma patients: A quantitative cytomorphometric analysis. Int J Health Sci (Qassim). 2015;9:283-291.
Chaudhary M, Venkatapathy R, Oza N, Prashad KV, Malik S. Evaluation of Micronuclei in Oral Squamous Cell Carcinoma: A Cytological Study. Int J Oral Care Res. 2017;5:4-8.
Greilhuber J. Cytochemistry and C-values: The Less-well-known World of Nuclear DNA Amounts. Ann Bot. 2008;101:791-804. doi: 10.1093/aob/mcm250
Mahimkar MB, Samant TA, Kannan S, Patil T. Influence of genetic polymorphisms on frequency of micronucleated buccal epithelial cells in leukoplakia patients. Oral Oncology. 2010;46:10:761-766.
Kohli M, Ahuja P, Mehendiratta M, Sharma M, Dutta J. Micronucleus Assay: An Early Diagnostic Tool to Assess Genotoxic Changes in Patients with Tobacco Use, Oral Leukoplakia and Oral Submucous Fibrosis. J Clin Diagn Res. 2017;11(9):28-32. doi: 10.7860/jcdr/2017/27711.10567
Hemamalini B. Comparison of Efficacy of Different Stains Used in Exfoliative Cytological Smears From Oral Lichen Planus Patients- A Pilot Study. IADR,Oral Med & Pathol. 2016;0529.
Ranjbar M, Motallebnejad M, Abbaszadeh H, Gholinia H. Micronuclei Comparison in Lichen Planus and Oral Lichenoid Responses. Babol Univ Med Sci. 2018;20:7-12.
Shah SN, Manjunatha BS, Shah S, et al. Quantitative evaluation of micronuclei in oral squamous cell carcinoma and oral submucous fibrosis patients: a comparative study. Rec Pat Anticanc Drug Discov. 2015;10:2:233-238. doi: 10.2174/1574892810666150317144817
Kabiraj A, Khaitan T, Bhowmick D, et al. Screening of Oral Potentially Malignant Disorders Using Exfoliative Cytology: A Diagnostic Modality. J Cancer Epidemiol. 2016;2016:8134832. doi: 10.1155/2016/8134832
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 European Journal of Clinical and Experimental Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.
